Training for Medical Oncologists on Shared Decision-Making About Palliative Chemotherapy: A Randomized Controlled Trial.
Inge HenselmansHanneke W M van LaarhovenHanneke C J M de HaesMeltem TokatEllen G EngelhardtPomme E A van MaarschalkerweerdMarleen KunnemanPetronella B OttevangerSerge E DohmenGeert-Jan CreemersDirkje W SommeijerFilip Y F L de VosEllen M A SmetsPublished in: The oncologist (2018)
Systemic treatment for advanced cancer offers uncertain and sometimes limited benefit, while the burden can be high. Hence, applying the premises of shared decision-making (SDM) is recommended. SDM is increasingly advocated based on the ethical imperative to provide patient-centered care and the increasing evidence for beneficial patient outcomes. Few studies examined the effectiveness of SDM training in robust designs. This randomized controlled trial demonstrated that SDM training (10 hours) improves oncologists' performance in consultations with standardized patients. The next step is to examine the effect of training on oncologists' performance and patient outcomes in clinical practice.
Keyphrases
- advanced cancer
- palliative care
- randomized controlled trial
- virtual reality
- end stage renal disease
- healthcare
- clinical practice
- chronic kidney disease
- newly diagnosed
- systematic review
- peritoneal dialysis
- study protocol
- squamous cell carcinoma
- radiation therapy
- risk factors
- pain management
- combination therapy
- chronic pain
- locally advanced
- quality improvement
- health insurance